Pierre Nahon

机构：Inserm, Sorbonne Université, Université Sorbonne Paris Nord, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Centre Hospitalier Universitaire de Caen Normandie, Hôpital Avicenne, Université de Caen Normandie

发表论文 5 篇 · 总被引 63 次 · h-index 4

代表论文

• Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment (2020 · Clinical Gastroenterology and Hepatology · 被引 26)
• Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial (2025 · Journal of Hepatology · 被引 19)
• Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma (2017 · Oncotarget · 被引 12)
• Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort (2020 · Clinics and Research in Hepatology and Gastroenterology · 被引 5)
• Cirrhosis is an independent risk factor for candidemia in critically ill patients: A 6-year single-center observational study (2025 · Anaesthesia Critical Care & Pain Medicine · 被引 1)